Efficacy of Once-Nightly Sodium Oxybate (FT218) in Narcolepsy Type 1 and Type 2: Post Hoc Analysis From the Phase 3 REST-ON Trial.

Yves DauvilliersThomas RothRichard K BoganMichael J ThorpyAnne Marie MorseAsim RoyJordan DubowJennifer Gudeman

Published in: Sleep (2023)

Clinically meaningful improvements of a single ON-SXB bedtime dose were shown for daytime sleepiness and DNS in NT1 and NT2, with less power for the limited NT2 subgroup.

Keyphrases

obstructive sleep apnea
sleep quality
phase iii
clinical trial
study protocol
sleep apnea
positive airway pressure
physical activity
open label